why choose us

First received: October 10, 2023

Clinical Trial: National Liver Cancer Biomarker Screening Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Carcinoma, Hepatocellular

Study Type: INTERVENTIONAL


Official Title: National Liver Cancer Biomarker Screening Trial

Brief Summary: The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection.Eligible patients will be randomized in a 1:1 fashion to Arm A using semi-annual ultrasound and AFP-based screening or Arm B using semi-annual screening using GALAD alone.Randomization will be stratified by sex, enrolling site, Child Pugh class (A vs. B), and HCC etiology (viral…

Read more